Cargando…

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

Detalles Bibliográficos
Autores principales:	Itzhaki Ben Zadok, Osnat, Ben-Avraham, Ben, Nohria, Anju, Orvin, Katia, Nassar, Mithal, Iakobishvili, Zaza, Neiman, Victoria, Goldvaser, Hadar, Kornowski, Ran, Ben Gal, Tuvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Clinical Case Challenges
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352193/ https://www.ncbi.nlm.nih.gov/pubmed/34396174 http://dx.doi.org/10.1016/j.jaccao.2019.07.004

Ejemplares similares

A Picture Is Worth 2,000 Words
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2023)

Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2021)

A rare case of Takotsubo syndrome in a patient 5 months after heart transplantation
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019)

Self‐care behaviours of patients with left ventricular assist devices in Israel: changes during the COVID‐19 pandemic
por: Melnikov, Semyon, et al.
Publicado: (2023)

Cardiomyopathy associated with Ceutzfeld–Jakob disease: a diagnosis of exclusion: a case report
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2020)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
por: Nardi Agmon, Inbar, et al.
Publicado: (2022)

Anti-immunoglobulin-like transcript 3 induced acute myocarditis—A case report
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2022)

Ventricular Assist Devices: Challenges of the One-device Era
por: Moady, Gassan, et al.
Publicado: (2022)

Health‐related quality of life in left ventricular assist device‐supported patients
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2021)

Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2022)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Exergaming in patients with a left ventricular assist device: a feasibility study
por: Hammer, Yoav, et al.
Publicado: (2022)

A rise in left atrial pressure detected by the V‐LAP™ system for patients with heart failure during the coronavirus disease 2019 pandemic
por: Perl, Leor, et al.
Publicado: (2020)

Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
por: Ramayya, Tarun, et al.
Publicado: (2022)

Report from a large and comprehensive single-center Women’s Health Cardiology Clinic
por: Schuchalter Ludmir, Shlomit, et al.
Publicado: (2021)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Elasomeran: Acute fulminant lymphocytic myocarditis and cardiogenic shock: case report
Publicado: (2022)

An Undetected Pheochromocytoma Leading to Fulminant Adrenergic Myocarditis Complicated by Cardiogenic Shock
por: Tran, Nam Q, et al.
Publicado: (2023)

Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study
por: Grossman, Shelly Meron, et al.
Publicado: (2021)

Fulminant Giant Cell Myocarditis and Cardiogenic Shock: An Unusual Presentation of Malignant Thymoma
por: Koul, Deepak, et al.
Publicado: (2010)

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

Short-term use of “ECMELLA” in the context of fulminant eosinophilic myocarditis with cardiogenic shock
por: Bohné, Mintje, et al.
Publicado: (2020)

Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock
por: Tadokoro, Naoki, et al.
Publicado: (2021)

Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022)

Pheochromocytoma presenting as fulminant myocarditis mimicking COVID‐19 pneumonia
por: Rojbi, Imen, et al.
Publicado: (2021)

The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond
por: Gilon, Dan, et al.
Publicado: (2022)

Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient
por: Ghafoor, Khuzema, et al.
Publicado: (2021)

Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma
por: Martz, Colin A., et al.
Publicado: (2021)

The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2023)

Heartmate 3 as a bridge to heart transplantation in a patient with congenitally corrected transposition of the great arteries: a case report
por: Barac, Yaron D., et al.
Publicado: (2022)

Sinus Arrest and Cardiogenic Shock Precipitated by Immune Checkpoint Inhibitors
por: Kumar, Kris, et al.
Publicado: (2020)

Fulminant Cardiotoxicity in a Patient With Cardiac Lymphoma Treated With CAR-T Cells
por: Koch, Christian, et al.
Publicado: (2022)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection presented with cardiogenic shock in a young patient
por: Avşar, Şahin, et al.
Publicado: (2019)

Fulminant Influenza A myocarditis in a patient presenting with cardiogenic shock and biventricular thrombi: a case report
por: Cottet, Mylène, et al.
Publicado: (2022)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Fulminant cardiogenic shock due to cardiac sarcoidosis
por: Genovese, Leonard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_biqq71vg2qo26jmpqgobnku32m